Using a combination of 160 high-resolution tungsten leaves and dramatically faster leaf movement, Elekta’s revolutionary new Agility™* MLC promises a new level of precision and delivery speed in radiation therapy treatments for cancer patients. Elekta recently received 510(k) clearance (K121328) from the U.S. Food and Drug Administration (FDA) for Agility, enabling U.S. medical centers to provide these clinical benefits to their patients with cancer.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55638-elekta-agility-radiation-therapy-radiotherapy-cancer-sbrt
Rheumatologists rely on medical transcription services for accurate records and to overcome issues like complex terminology, multiple diagnoses and so on.
Today, the GUINNESS WORLD RECORDS® record for the “Most people using mouthwash simultaneously” was broken by Colgate at 12:30 p.m. EDT in New York’s Times Square. 1,142 consumers, along with TV host and actress, Stacy Keibler, simultaneously swished with new Colgate Total® Advanced Pro-Shield™ Mouthwash while supporting Make-A-Wish®, an organization that creates thousands of life-changing moments by granting the wishes of children with life-threatening medical conditions.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/61754-colgate-stacy-keibler-guinness-world-records-for-make-a-wish-foundation
Travel Insurance also know as Visitors Insurance is a insurance that is intended to cover medical expenses and financial (such as money invested in nonrefundable pre-payments) and other losses incurred while traveling, either within one's own country, or internationally. Student travel, adventure travel, business travel, cruise travel, leisure travel, and international travel are all the options that can be insured through MatrixIA
Ahead of World Stroke Day 2012 (October 29), European Policy Makers have joined over 90 Medical and Patient Organisations, and more than 100,000 people, in supporting the Global Atrial Fibrillation (AF) Patient Charter and calling for National Governments and the World Health Organisation to act to make the prevention of AF-related strokes a priority. The Charter outlines ways to improve the diagnosis and management of AF which, if implemented, could stop thousands of preventable strokes from occurring each and every year.
To view Multimedia News Release, go to http://www.multivu.com/players/English/57497-sign-against-stroke/
When searching the pharmacy shelves, people looking for help to support healthy good cholesterol with a dietary supplement niacin may inaccurately associate the ingredient nicotinic acid with smoking cessation because it sounds like nicotine, warns leading cardiologist, Dr. Carl Lavie, Medical Director of Cardiac Rehabilitation and Prevention at the John Ochsner Heart and Vascular Institute, New Orleans, LA. In fact, nicotinic acid is the only form of dietary supplement niacin that is clinically proven to support good cholesterol, also known as high-density lipoprotein cholesterol, or HDL.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58806-upsher-smith-cardiologist-advice-niacin-nicotinic-acid-flush-free
University Hospitals Case Medical Center was recognized today as a national model for quality care as the recipient of the 2012 American Hospital Association-McKesson Quest for Quality Prize. The prestigious award named UH Case Medical Center the top hospital in the nation for its leadership and innovation in quality improvement and safety.
UH Case Medical Center was selected by a multi-disciplinary committee of health care quality and patient safety experts. The American Hospital Association (AHA)-McKesson Quest for Quality Prize is presented annually and UH Case Medical Center is the first large, urban academic medical center to earn this coveted prize.
To view Multimedia News Release, go to https://www.multivu.com/mnr/57289-american-hospital-association-uh-case-medical-center-leader-in-quality
Eight out of 10 people will be affected by back pain at some point during their lives, making it the No. 1 cause of disability worldwide and resulting in as much as $200 billion in lost wages and productivity. Many sufferers struggle for years to find relief, but treatment options often only provide short-term relief or, in the case of pain medication, carry serious side effects, including drowsiness, liver damage and potential for addiction. Now, thanks to Hocoma, a leader in the development of robotic and sensor-based medical devices for functional movement therapy, consumers have a new way to improve and sustain low back health in the comfort of their own home.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7370551-hocoma-innovative-medical-device-therapeutic-gaming-technology-valedo-low-back-health/
Asuragen Inc., a leading molecular diagnostics company, today announced results from a study demonstrating that a new molecular test called Xpansion Interpreter® can improve the determination of a woman’s risk of having a child with fragile X syndrome, the most common inherited cause of intellectual disability and autism, compared to existing risk measures. The Xpansion Interpreter Test is based on a technology breakthrough that reveals both the number and position of “interrupting” DNA sequences in the fragile X gene of the mother and more accurately estimates the likelihood that her child will have fragile X syndrome. The study will be published in the April issue of the American Journal of Medical Genetics and presented today at the 2013 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting in Phoenix, AZ.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60719-asuragen-xpansion-interpreter-xi-test-data-fragile-x-syndrome-autism
SIRO Clinpharm, a leading full service clinical research organization, unveiled its new brand identity on Friday. The new look affirms the recent transformation in the company’s business strategy.
“With the vast experience garnered over the past 16 years, SIRO was set to take a leap forward. With its customer centric leadership, we have built depth in various areas of competencies, leveraging our 4 pillars – people, processes, technologies and solutions,” said Dr. Gautam Daftary, founder and chairman, SIRO Clinpharm.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58672-SIRO-Clinpharm-unveils-new-brand-identity
Crosstex International, a subsidiary of Cantel Medical Corp. (NYSE:CMN), and Prestige Ameritech, the only two major U.S.-based medical mask manufacturers have joined forces to bring attention to a glaring void in public health research and policy – that, if addressed, has the potential to more quickly provide a simple, effective tool to mitigate the spread of influenza and other respiratory borne viruses. The awareness campaign comes in response to a new study, “ Exposure to Influenza Virus Aerosols During Routine Patient Care,” published in The Journal of Infectious Diseases, showing that influenza viruses may spread as far as six feet from a person coughing or sneezing, and that some people, referred to as “super spreaders,” may be more likely to spread the virus. The study, supported by the Department of Health and Human Services with a $600,000 research grant, pointed specifically to concerns for healthcare workers being exposed to coughs from sick patients. Yet government research and policy continues to overlook face masks as a feasible protection measure for both the healthcare industry and the general public.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60417-cantel-medical-fitted-mask-infectious-disease-control-public-health-policy
